• 

  An HIV Drug to Treat Alzheimer’s? Researchers See Promising Results in Mice
• 

  Phil’s Journal: After My Early Onset Alzheimer’s Diagnosis, Writing About It Became Cathartic
• 

  Biogen Cancels Another Dementia Drug in Phase 2 Clinical Trial
• 

  $350 Million to Be Given to Alzheimer’s Research in 2020 Funding Bill
• 

  Yoga Benefits the Brain and May Reduce Risk of Alzheimer’s
• 

  Will Biogen’s Drug Aducanumab Solve the Alzheimer’s Mystery?
• 

  There’s More to Alzheimer’s Than Your Genes: Researchers Find Clues By Studying Identical Triplets
• 

  Researchers Pinpoint Brain Process That May Lead to Amyloid Buildup
• 

  Can Coffee Protect Your Brain From Alzheimer’s?
• 

  The Perception of Decline: Life Following a Dual Diagnosis of Alzheimer’s and Lewy Body Dementia
• 

  Healthy Blood Vessels, Healthy Brain
• 

  For Alzheimer’s Patient, Hope Renewed Following Biogen Announcement
• 

  Phil’s Journal: Seeking to Understand the Science Behind Biogen’s Alzheimer’s Drug
• 

  Biogen Reports Drug Effective in Slowing Alzheimer’s Disease: ‘A Milestone Achievement’
• 

  CTAD: Day One Round-up—Biogen, Blood Pressure Control

Previous105106107Next